Answers are grounded in this paper and cite their sources.
Objective: To discuss the diagnostic potential of salivary biomarkers in oral squamous cell carcinoma, considering their ability to distinguish it from oral potentially malignant disorders and the limitations affecting clinical application. Literature review: Saliva is an accessible, noninvasive source of components related to the tumor microenvironment. Cytokines, matrix metalloproteinases, cell-free DNA, microRNAs, exosomes, proteins, autoantibodies, and metabolites show alterations associated with carcinoma. MMP-9, salivary cell-free DNA integrity, and selected microRNAs have yielded promising findings, while multibiomarker panels have generally performed better than isolated molecules. However, heterogeneous protocols, small samples, the influence of oral inflammatory conditions, and limited external validation hinder comparison across studies and clinical implementation. Final considerations: Salivary biomarkers show potential as complementary tools for screening and diagnostic support, but they do not replace clinical assessment or histopathological confirmation. Prospective, multicenter, standardized studies are required to validate their applicability across independent populations and healthcare settings before routine clinical use.
No takes yet. Share an insight, caveat, or question.
Calado et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: